Alkem Laboratories share price
Alkem Laboratories Ltd. · NSE: ALKEM · Healthcare
Price, one year
Price range
- Open
- ₹4,975.50
- High
- ₹5,019.50
- Low
- ₹4,877.00
- Previous close
- ₹5,013.50
- Volume
- 54,982
- Market cap
- ₹59,149 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 27.4
- Price to book
- 4.3
- Return on equity
- 15.6%
- EPS (TTM)
- ₹180.44
- Book value / share
- ₹1,155.87
- Debt to equity
- 0.11
- Revenue (TTM)
- ₹15,081 Cr
- Net profit (TTM)
- ₹2,158 Cr
- Sales growth, YoY
- +10.9%
- Profit growth, YoY
- −21.7%
- Operating margin
- 20.1%
- Net margin
- 14.3%
- Sales CAGR, 3 years
- +8.2%
- Profit CAGR, 3 years
- +32.7%
- Promoter holding
- 49.70%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Promoters | 51.20 | 51.20 | 49.70 |
| Foreign institutions | 9.97 | 10.16 | 10.42 |
| Domestic institutions | 21.54 | 21.40 | 22.63 |
| Mutual funds | 16.06 | 15.57 | 16.71 |
| Retail and others | 17.09 | 17.06 | 17.04 |
Futures and options
23 Oct 2026- Lot size
- 125
- Put-call ratio (OI)
- 1.31
- Max pain
- ₹5,150.00
- Highest call OI strike
- 5,500.00
- Highest put OI strike
- 5,000.00
- ATM implied volatility
- 26.9% IV rank 47
- Futures basis
- −0.42%
- Rollover
- 51.8%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 23 Oct | Long unwinding | −1.56% | −2.66% |
| 22 Oct | Long buildup | +0.28% | +0.90% |
| 21 Oct | Short buildup | −0.28% | +0.20% |
| 19 Oct | Long unwinding | −1.07% | −0.43% |
| 16 Oct | Short buildup | −1.50% | +2.87% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 14 Aug 2026.
- 21 Oct 2026 · OtherInitiation of Forensic AuditAlkem Laboratories Limited has informed the Exchange about Initiation of Forensic Audit
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Alkem Laboratories today?
Alkem Laboratories (NSE: ALKEM) was at ₹4,947.00 on 23 Oct 2026, a change of −1.33% from the previous close.
What are the 52-week high and low of Alkem Laboratories?
Over the last 52 weeks Alkem Laboratories traded between ₹4,811.00 and ₹5,933.50 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Alkem Laboratories?
About ₹59,149 Cr at the latest price, with a P/E of 27.4, a price-to-book of 4.3, a return on equity of 15.6%. Ratios use the company's latest reported results.
Who owns Alkem Laboratories shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Jun 2026, promoters held 49.70%, foreign institutions 10.42%, domestic institutions 22.63%.
Is Alkem Laboratories traded in futures and options?
Yes, ALKEM is in NSE's futures and options segment. The lot size is 125 shares.
Which sector and indices does Alkem Laboratories belong to?
NSE classifies Alkem Laboratories under Healthcare; it is a member of Nifty 500.
Follow Alkem Laboratories with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial